OGJ

(2S)-2-(4-{2-[3-(fluoromethyl)azetidin-1-yl]ethoxy}phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-1-benzopyran-6-ol


Toggle HydrogenToggle Labels

Chemical Component Summary

Name(2S)-2-(4-{2-[3-(fluoromethyl)azetidin-1-yl]ethoxy}phenyl)-3-(3-hydroxyphenyl)-4-methyl-2H-1-benzopyran-6-ol
Identifiers(2~{S})-2-[4-[2-[3-(fluoranylmethyl)azetidin-1-yl]ethoxy]phenyl]-3-(3-hydroxyphenyl)-4-methyl-2~{H}-chromen-6-ol
FormulaC28 H28 F N O4
Molecular Weight461.525
TypeNON-POLYMER
Isomeric SMILESCC1=C([C@@H](Oc2c1cc(cc2)O)c3ccc(cc3)OCCN4CC(C4)CF)c5cccc(c5)O
InChIInChI=1S/C28H28FNO4/c1-18-25-14-23(32)7-10-26(25)34-28(27(18)21-3-2-4-22(31)13-21)20-5-8-24(9-6-20)33-12-11-30-16-19(15-29)17-30/h2-10,13-14,19,28,31-32H,11-12,15-17H2,1H3/t28-/m0/s1
InChIKeyKJAAPZIFCQQQKX-NDEPHWFRSA-N

Chemical Details

Formal Charge0
Atom Count62
Chiral Atom Count1
Bond Count66
Aromatic Bond Count18

Drug Info: DrugBank

DrugBank IDDB14934 
NameGDC-0927
Groups investigational
DescriptionGDC-0927 is under investigation in clinical trial NCT02316509 (A Study of GDC-0927 in Postmenopausal Women With Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer).
SynonymsGDC-0927
CAS number2100830-77-9

Related Resource References

Resource NameReference
PubChem 87055263